Navigation Links
Fetal Cell Transplant Found To Improve Movement In Patients With Parkinson’s Disease

Latest research shows that fetal cell transplantation for patients with Parkinson’s disease is helping some patients get rid of their medications altogether.//

Parkinson’s disease is a chronic neurological disease that impairs mobility. Patients with Parkinson’s lack the chemical dopamine, which is necessary for movement. Fetal cell transplantation involves transplanting aborted human fetal tissue to replace the lost dopamine-producing cells to help restore movement.

Levodopa (Dopar or Larodopa) is the gold standard treatment for Parkinson’s disease. While the drug offers substantial relief, research shows it tends to lose its effectiveness after five to 10 years of use. Researchers say after one year, the transplant is equivalent to about 30-percent of the levodopa people take. After two years, it’s equivalent to about 50 percent. By the third year, the procedure’s effect is about 60 percent, or two-thirds, the effect of the drug and they say, that it is enough for some people to stop taking their drgs.
'"/>




Page: 1

Related medicine news :

1. Fish Found To Improve Fetal Growth
2. Vitamin Supplements During Pregnancy to Boost Fetal Development
3. Worried About The Sensitive Skin Of Your 2 Year Old? Fetal Skin Cells To Offer Help
4. Using Eyes As The Line Of Reference For Fetal Brain Imaging
5. Simple Eye Movement Test For Early Detection Of Fetal Alcohol Spectrum Disorder
6. Genetic Disorders, Not Fetal Distress Increase Cerebral Palsy Risk
7. Fetal Development Face The Threat By Frequent Ultrasounds
8. New Drug Could Prevent Fetal Alcohol Syndrome
9. Fetal Neural Grafts Improves Motor and Cognitive Function in Huntington Patients
10. Epilepsy Drug Poses High Risk for Fetal Death and Birth Defects
11. Americans Deficient In Dietary Intake Of Choline Needed for Fetal Brain Development
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology: